All News

Cancer and the Butterfly Effect

February 3rd 2023

Reflecting on World Cancer Day got me thinking about butterflies, a symbol of hope, but, according to the “Butterfly Effect” theory, a small flap of their wings could have major impacts on the world, which is not very different from cancer.

FDA Approves Trodelvy for HER2-Negative, HR-Positive Metastatic Breast Cancer

February 3rd 2023

The Food and Drug Administration approved Trodelvy for patients with pretreated, unresectable HR-positive, HER2-negative metastatic breast cancer.

Momelotinib Continues to Demonstrate Symptom Benefit for Patients With Myelofibrosis

February 3rd 2023

If approved by the FDA later this year, momelotinib could fulfill an area of unmet need for patients with myelofibrosis, according to an expert.

Medicaid Expansion Associated With Improved Breast Cancer Outcomes

February 2nd 2023

Patients with breast cancer who lived in Southern states with Medicaid expansion were less likely to be diagnosed with metastatic disease and more likely to receive treatment.

Despite Rapid Increase in Immunotherapy Use for Lung Cancer, Survival Benefit for Older Patients Is Modest

February 2nd 2023

Since 2015, the use of immunotherapies has increased for both young and older patients, but the survival benefit is more evident in younger patients, findings demonstrated.

I’m No Longer Stubborn When It Comes to Cancer Screenings

February 2nd 2023

Many men — my former self included — can be stubborn when it comes to cancer screenings or visiting the doctor. Thankfully I’ve changed my ways, which saved my life.

Teaching Children — and the World — to Use Breathing Techniques for Cancer-Related Pain

February 2nd 2023

In this episode of the “Cancer Horizons” podcast, “Rabbi G” discusses his global travels to teach breathwork to children with cancer, and gives an exercise listeners can use to decrease their pain and anxiety.

How Cancer Saved Me

February 2nd 2023

While cancer is a horrible disease, it taught me some valuable lessons.

Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer

February 1st 2023

The first patient was dosed with lerapolturev in a phase 1/2 clinical trial evaluating the drug in patients with bladder cancer and other solid tumors.

Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs

February 1st 2023

A new standard of care for advanced pancreatic neuroendocrine tumors demonstrates improvements in survival and tumor shrinkage.

Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer

February 1st 2023

I’m coming up on my 10-year cancer anniversary, and it feels bittersweet.

Taking 8-Plus Medications Before Cancer Treatment May Affect Effectiveness in Older Patients

February 1st 2023

Older patients with advanced cancer who were taking eight or more medications before starting treatment were more likely to discontinue treatment and/or experience a side effect from drug interactions.

CAR-T Cell Therapy May Confer Responses in Relapsed/Refractory CLL or SLL, Preliminary Data Shows

February 1st 2023

The TRANSCNED CLL 004 trial met its primary endpoint of complete responses with the CAR-T cell therapy Breyanzi in patients with relapsed or refractory CLL or SLL.

Cancer Care Improvements Have Come ‘Leaps and Bounds’ Over the Years

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about how cancer care has changed over the years.

Oncologists Have Feelings Too: Navigating the Patient Physician Relationship

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about how patients can better understand the emotions their oncologists may be going through during treatment.

Debunking Myths of Clinical Trials for Cancer

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about clinical trials in cancer care.

Highlighting Geographic, Economic Disparities in Cancer Care

January 31st 2023

Jumping Through Insurance Hoops for Treatment

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about the challenges patients and physicians face with insurance matters during cancer care.

Immunotherapy Combination ‘Huge Benefit’ for Some Patients With Colorectal Cancer

January 31st 2023

Patients with refractory metastatic colorectal cancer often don’t have many effective treatment options, although immunotherapy may be a promising potential for patients based on recent study findings.

Cancer Made Me Superstitious

January 31st 2023

After being diagnosed with cancer, I’m nervous to plan for my future, and can’t say I’m in remission without knocking on wood.

Prostate Cancer Symptoms Can Be Managed Years After Treatment

January 31st 2023

An expert on urological side effects of cancer treatments most often associated with prostate cancer discusses options, even for those decades past initial treatment.

Trial to Investigate If Novel Drug Combo Can Boost Outcomes in Lung Cancer

January 31st 2023

A phase 3 trial will test datopotamab deruxtecan in combination with Keytruda with or without chemotherapy for certain patients with metastatic non-small cell lung cancer.

Understanding Robotic Surgery in Cervical Cancer

January 30th 2023

Efficacy with robotic surgery in early-stage cervical cancer is currently being studied, to hopefully offer patients an option with better recovery compared to open surgery.

Brukinsa Offers Better Response and Less Toxicity for CLL and SLL Treatment, But a Cure Is Still Needed

January 30th 2023

Two experts explain what patients need to know about the recent approval of Brukinsa for patients with chronic lymphocytic leukemia and small lymphocytic leukemia.

My Dog’s Love Gave Me the Will to Live During Cancer

January 30th 2023

After being diagnosed with leukemia, my Golden Retriever, Payton, was my emotional caregiver and gave me the will to live.

On Cancer and Careers: How a Diagnosis Changed Survivors’ Jobs

January 30th 2023

We asked our audience of cancer survivors how their diagnosis affected their careers. Here’s what they had to say.

Ongoing Trial Shows Positive Response Rates With MEK Inhibitor Combo in Ovarian Cancer Subset

January 30th 2023

Women with low-grade serous ovarian cancer treated with avutometinib and defactinib experienced positive response rates compared with avutometinib alone.

Adjuvant Chemoradiotherapy Demonstrated Better Outcomes for Patients With Endometrial Cancer

January 29th 2023

Chemoradiotherapy may be an appropriate treatment option after surgery for patients with stage 3 endometrial cancer, especially those are a higher risk of recurrence.

As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis

January 28th 2023

I was shocked when I was diagnosed with a myeloproliferative neoplasm, and have dedicated myself to learning about the disease since.

First Patient Injected With Novel Radiotherapy in Phase 2b Trial for Brain Cancer

January 28th 2023

The treatment previously demonstrated significantly improved overall survival for patients with recurrent glioblastoma in a phase 1 study.